Project Number 20120504-LANDRETH-2012 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2012 View Full Project Details for A Randomized Controlled Study to Evaluate the Effect of Bexarotene, an RXR Agonist, on beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator LANDRETH, GARY E. Principal Investigator First Name GARY E. Principal Investigator Last Name LANDRETH Awardee Organization REXCEPTOR, INC. Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $750,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
